Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis identifies novel cancer associated fibroblast marker in the breast tumour microenvironment

ABSTRACT: Cancer associated fibroblasts (CAFs) contribute to tumourigenesis and immune tolerance within the tumour microenvironment (TME). However, the absence of specific molecular markers complicates selective CAF targeting. This study aims to identify novel CAF-specific biomarkers with dual functionality: enhancing anti-tumor immunity and suppressing malignant progression. To address this, we conducted comparative transcriptomic profiling via RNA sequencing of patient-matched CAFs and normal fibroblasts (NFs) isolated from the same breast cancer patient, revealing potential targets with therapeutic relevance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE296349 | GEO | 2025/05/10

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a hidden smoking-associated malignancy index of tumor microenvironment (Illumina 2)

Project description:Unlike the better-studied aberrant epigenome in the tumor, the clinicopathologic impact of DNA methylation in the tumor microenvironment (TME), especially cancer-associated fibroblast (CAF), remains elusive. CAFs exhibit profound patient-to-patient tumorigenic heterogeneity. However, molecular characterization on patient-derived CAFs with follow-up data is limited, hindering the progress of targeting CAFs in precision oncology. Here we developed a robust and efficient methylome/transcriptome co-analysis system to comprehensively profile CAFs and paired normal fibroblasts (NFs) from non-small-cell lung cancer patients (NSCLC) and revealed a hidden smoking-associated DNA methylation index that quantifies the malignancy level of TME. Out of 14,781 NF/CAF differentially methylated CpG sites, 3,707 (25%) showed higher methylation changes in ever-smokers than non-smokers. Further integrative analysis pinpointed to a specific subset of 54 CpG sites that we used to construct the index for detecting perturbation in CAFs. We applied this index to multiple lung cancer cohorts and confirmed the success in survival prediction. Effective quantification of premalignant status of individual TME adds a new dimension to precision oncology. Although smoking is a well-known risk factor for lung cancer and is associated with methylation in tumor DNA, the epigenomic/transcriptomic perspective on CAF/NF outperforms smoking itself as a clinicopathologic factor for NSCLC.

2025-05-01 | GSE149958 | GEO

DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a hidden smoking-associated malignancy index of tumor microenvironment (Illumina 1)

2025-05-01 | GSE149957 | GEO

DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a hidden smoking-associated malignancy index of tumor microenvironment (Affymetrix)

2025-05-01 | GSE149955 | GEO

Prognostic Gene Expression Signature of Carcinoma Associated Fibroblasts in Non-Small Cell Lung Cancer [methylation profiling]

Project description:The tumor microenvironment strongly influences cancer development, progression and metastasis. The role of carcinoma-associated fibroblasts (CAFs) in these processes and their clinical impact has not been studied systematically in non-small cell lung carcinoma (NSCLC). We established primary cultures of CAFs and matched normal fibroblasts (NFs) from 15 resected NSCLC. We demonstrate that CAFs have greater ability than NFs to enhance the tumorigenicity of lung cancer cell lines. Microarray gene expression analysis of the 15 matched CAF and NF cell lines identified 46 differentially expressed genes, encoding for proteins that are significantly enriched for extracellular proteins regulated by the TGF-beta signaling pathway. We have identified a subset of 11 genes that formed a prognostic gene expression signature, which was validated in multiple independent NSCLC microarray datasets. Functional annotation using protein-protein interaction analyses of these and published cancer stroma-associated gene expression changes revealed prominent involvement of the focal adhesion and MAPK signalling pathways. Fourteen (30%) of the 46 genes also were differentially expressed in laser-capture micro-dissected corresponding primary tumor stroma compared to the matched normal lung. Six of these 14 genes could be induced by TGF-beta1 in NF. The results establish the prognostic impact of CAF-associated gene expression changes in NSCLC patients. Methylation profiles of 5 pairs of were included in a molecular characterization of NSCLC fibroblast cell lines (CAFs) vs. normal lung fibroblasts (NFs). Methylation profiles of 5 paired primary NSCLC fibroblast cell lines (CAFs) and normal lung fibroblasts (NFs) were generated. Genes were determined to be hyper- and hypo-methylated based on paired analysis.

2011-04-08 | E-GEOD-27284 | biostudies-arrayexpress

Prognostic Gene Expression Signature of Carcinoma Associated Fibroblasts in Non-Small Cell Lung Cancer [genome variation profiling]

Project description:The tumor microenvironment strongly influences cancer development, progression and metastasis. The role of carcinoma-associated fibroblasts (CAFs) in these processes and their clinical impact has not been studied systematically in non-small cell lung carcinoma (NSCLC). We established primary cultures of CAFs and matched normal fibroblasts (NFs) from 15 resected NSCLC. We demonstrate that CAFs have greater ability than NFs to enhance the tumorigenicity of lung cancer cell lines. Microarray gene expression analysis of the 15 matched CAF and NF cell lines identified 46 differentially expressed genes, encoding for proteins that are significantly enriched for extracellular proteins regulated by the TGF-beta signaling pathway. We have identified a subset of 11 genes that formed a prognostic gene expression signature, which was validated in multiple independent NSCLC microarray datasets. Functional annotation using protein-protein interaction analyses of these and published cancer stroma-associated gene expression changes revealed prominent involvement of the focal adhesion and MAPK signalling pathways. Fourteen (30%) of the 46 genes also were differentially expressed in laser-capture micro-dissected corresponding primary tumor stroma compared to the matched normal lung. Six of these 14 genes could be induced by TGF-beta1 in NF. The results establish the prognostic impact of CAF-associated gene expression changes in NSCLC patients. Genotyping profiles of 4 pairs of were included in a molecular characterization of NSCLC fibroblast cell lines (CAFs) vs. normal lung fibroblasts (NFs). Genotyping profiles of 4 paired primary NSCLC fibroblast cell lines (CAFs) and normal lung fibroblasts (NFs) were generated. CNV was assessed using paired analysis.

2011-04-08 | E-GEOD-27289 | biostudies-arrayexpress

RNA-Sequencing data of patient derived normal fibroblasts (NFs), cancer associated fibroblasts (CAFs) and tumor spheroid samples

Project description:RNA-Sequencing data of patient derived normal fibroblasts (NFs), cancer associated fibroblasts (CAFs) and tumor spheroid samples performed in the context of the characterization of an IL1R1 positive CAF population in CRC tumour samples.

| EGAS00001007205 | EGA

Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [Illumina HM450]

Project description:Cancer Associated Fibroblasts (CAFs) play an active role in tumourigenesis. It is unknown how the permanent phenotypic changes in CAFs are encoded at the molecular level. Here we use whole genome sequencing and microarray analysis to interrogate the epigenome, transcriptome and genome of patient-matched CAF and non-malignant prostate fibroblast (NPF) cells.

2018-03-26 | GSE86258 | GEO

Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [HuGene-1_0-st]

2018-03-26 | GSE86256 | GEO

Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [WGBS]

2018-03-26 | GSE85609 | GEO

Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq]

2018-03-26 | GSE85606 | GEO